Brussels, 22/10/2014 (Agence Europe) - Speaking at the European Court of Justice on Tuesday 21 October, the Advocate General, Yves Bot, said that when a medical product model is potentially faulty or it is clearly dysfunctional in relation to normal standards, all the products from the same model should be deemed defective and it is up to the manufacturer to bear the costs relating to their surgical replacement.
In 2005, the Boston Scientific Medizintechnik GmbH (BSM) company informed...